Skip to main content

Table 1 Demographic and clinical characteristics of patients before and after CPAP therapy (n = 34)

From: The role of sleepiness on arterial stiffness improvement after CPAP therapy in males with obstructive sleep apnea: a prospective cohort study

Variables

Before CPAP

After CPAP

p-value

Age

55.2 (7.9)

BMI

31.2 (4.1)

31.3 (4.0)

0.901

Smoking

7 (20.6)

ESS >10

8.4 (4.3)

4.8 (2.7)

<0.001*

AHI (events/h)

35.2 (18.8)

2.6 (2.3)

<0.001

ODI (events/h)

25.5 (20.0)

Mean SaO2 (%)

92.1 (2.1)

Lower SaO2 (%)

79.8 (8.5)

SaO2 < 90% (%)

17.7 (18.5)

Total cholesterol, mg/dl

198.2 (32.9)

187.4 (36.0)

0.021

HDL-cholesterol, mg/dl

44.3 (10.3)

44.5 (11.0)

0.678

LDL-cholesterol, mg/dl

131.0 (29.4)

121.5 (30.8)

0.031

Triglycerides, mg/dl

137.9 (51.0)

126.6 (59.6)

0.124

Glucose, mg/dl

98.7 (12.8)

98.2 (11.7)

0.924

HbA1c, %

5.7 (0.4)

5.8 (0.4)

0.064

24 h SBP (mm Hg)

129.8 (10.5)

128.0 (10.3)

0.287

24 h DBP (mm Hg)

82.4 (7.1)

79.2 (6.4)

0.004

Pulse pressure (mm Hg)

47.4 (7.3)

48.8 (8.1)

0.050

24 h MBP (mm Hg)

97.4 (7.9)

94.9 (7.2)

0.030

Day-time SBP (mm Hg)

133.3 (10.5)

131.2 (10.9)

0.214

Day-time DBP (mm Hg)

85.4 (7.3)

81.6 (6.9)

0.001

Night-time SBP (mm Hg)

117.9 (12.6)

116.4 (9.5)

0.363

Night-time DBP (mm Hg)

72.1 (9.1)

70.1 (5.9)

0.169

Hypertension n (%)

27 (79.4)

25 (73.5)

0.500*

Antihypertensive drugs, n (%)

21 (61.8)

Dyslipidaemia n (%)

28 (82.4)

24 (70.6)

0.125*

Lipid lowering drugs n (%)

14 (41.2)

MetS n (%)

21 (61.8)

20 (58.8)

1.000*

Cf-PWV (m/s)

12.3 (2.3)

11.7 (1.8)

0.086

  1. Results are expressed as mean (standard deviation); *p-values obtained by McNemar test; remaining p-values were obtained by Wilcoxon rank exact test
  2. CPAP continuous positive airway treatment, BMI Body mass index, ESS Epworth Sleepiness Scale, AHI Apnea/Hypopnea Index, ODI Oxygen Desaturation Index, SaO 2 arterial oxygen saturation, HbA1c glycated haemoglobin, SBP systolic blood pressure, DBP diastolic blood pressure, MetS metabolic syndrome, cf-PWV carotid-femoral pulse wave velocity